Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study.
about
Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Autoimmunity and autoimmune co-morbidities in psoriasis.Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis.Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
P2860
Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@en
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@nl
type
label
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@en
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@nl
prefLabel
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@en
Impact of adalimumab treatment ...... sis: Results of a pilot study.
@nl
P2093
P2860
P356
P1476
Impact of adalimumab treatment ...... asis: Results of a pilot study
@en
P2093
Jana Potockova
Monika Arenbergerova
Pavel Kraml
Petra Gkalpakioti
Spyridon Gkalpakiotis
P2860
P304
P356
10.1111/1346-8138.13661
P50
P577
2016-10-24T00:00:00Z